The global scale inhibitors market (a subset including silica-targeted antiscalants) is forecast from USD 2.23 billion in 2024 to ~USD 3.22 billion by 2032 at ~4.7% CAGR. Other sources estimate USD 3.5 billion in 2022 growing to USD 4.7–5.9 billion by 2029–31 (CAGR ~4.7–5.4%). The polymeric scale inhibitors segment alone was valued at USD 1.5 billion in 2024 and is expected to grow to USD 2.3 billion by 2031 at ~5.2% CAGR.